Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.72
-0.24 (-1.60%)
Mar 20, 2026, 11:34 AM EDT - Market open
Olema Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$44.89
Upside
+204.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $43 → $40 | Strong Buy | Initiates | $43 → $40 | +171.74% | Mar 19, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $55 → $58 | Buy | Maintains | $55 → $58 | +294.02% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $38 → $27 | Strong Buy | Maintains | $38 → $27 | +83.42% | Mar 18, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $60 → $62 | Strong Buy | Maintains | $60 → $62 | +321.20% | Mar 17, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | +158.15% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +158.15% | Mar 9, 2026 |
| Stifel | Stifel | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +226.09% | Feb 11, 2026 |
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +205.71% | Jan 7, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $21 → $60 | Strong Buy | Maintains | $21 → $60 | +307.61% | Dec 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +226.09% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $38 | Strong Buy | Maintains | $26 → $38 | +158.15% | Dec 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $45 | Strong Buy | Maintains | $36 → $45 | +205.71% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $26 | Strong Buy | Maintains | $18 → $26 | +76.63% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $36 | Strong Buy | Maintains | $28 → $36 | +144.57% | Nov 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $45 | Buy | Maintains | $22 → $45 | +205.71% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +117.39% | Nov 18, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.